ILC2s and Basophils Team Up to Orchestrate IL-33–Induced Atopic Dermatitis
Bernhard Ryffel,José C. Alves‐Filho
DOI: https://doi.org/10.1016/j.jid.2019.06.118
2019-01-01
Abstract:In this issue, Imai et al. (2019) provide new insights into the pathophysiology of AD-like inflammation using their model (Imai et al., 2013) and ask how ILC2s and basophils contribute to the IL-33–induced AD-like inflammation. Their findings show that continuous expression of IL-33 in keratinocytes is sufficient to cause AD-like inflammation in mice, and that this occurrence is largely independent of adaptive immune cells and is mediated by basophils and ILC2s. In this issue, Imai et al. (2019) provide new insights into the pathophysiology of AD-like inflammation using their model (Imai et al., 2013) and ask how ILC2s and basophils contribute to the IL-33–induced AD-like inflammation. Their findings show that continuous expression of IL-33 in keratinocytes is sufficient to cause AD-like inflammation in mice, and that this occurrence is largely independent of adaptive immune cells and is mediated by basophils and ILC2s. Clinical Implications•IL-33–driven AD is independent of adaptive immunity.•Keratinocyte-derived IL-33 activates basophils, which induce ILC2s.•Basophil depletion in this context is of potential therapeutic interest.Atopic dermatitis (AD) is an important clinical disease with different, often severe, manifestations. Causative agents may include chemicals of environmental or plant origin; genetic predisposition factors are also relevant (Weidinger and Novak, 2016Weidinger S. Novak N. Atopic dermatitis.Lancet. 2016; 387: 1109-1122Abstract Full Text Full Text PDF PubMed Scopus (1154) Google Scholar). Mechanistic insights may be obtained from mouse models (Nakajima et al., 2019Nakajima S. Nomura T. Common J. Kabashima K. Insights into atopic dermatitis gained from genetically defined mouse models.J Allergy Clin Immunol. 2019; 143: 13-25Abstract Full Text Full Text PDF PubMed Scopus (39) Google Scholar). Experimentally, AD can be induced by the topical application of proteins, chemicals, inflammatory cytokines, histamines, and other mediators that distort the epithelial immune microenvironment (Dainichi et al., 2018Dainichi T. Kitoh A. Otsuka A. Nakajima S. Nomura T. Kaplan D.H. et al.The epithelial immune microenvironment (EIME) in atopic dermatitis and psoriasis.Nat Immunol. 2018; 19: 1286-1298Crossref PubMed Scopus (173) Google Scholar). IL-33 is a pleiotropic cytokine playing a pivotal role in allergic disorders, including AD (Liew et al., 2016Liew F.Y. Girard J.P. Turnquist H.R. Interleukin-33 in health and disease.Nat Rev Immunol. 2016; 16: 676-689Crossref PubMed Scopus (625) Google Scholar). Intradermal injection of IL-33 in the skin caused psoriasis-like neutrophilic inflammation with mast cell activation in mice (Hueber et al., 2011Hueber A.J. Alves-Filho J.C. Asquith D.L. Michels C. Millar N.L. Reilly J.H. et al.IL-33 induces skin inflammation with mast cell and neutrophil activation.Eur J Immunol. 2011; 41: 2229-2237Crossref PubMed Scopus (135) Google Scholar). Topical application of calcipotriol (a vitamin D3 analogue) induces expression of thymic stromal lymphopoietin (Li et al., 2006Li M. Hener P. Zhang Z. Kato S. Metzger D. Chambon P. Topical vitamin D3 and low-calcemic analogs induce thymic stromal lymphopoietin in mouse keratinocytes and trigger an atopic dermatitis.Proc Natl Acad Sci USA. 2006; 103: 11736-11741Crossref PubMed Scopus (356) Google Scholar) and causes IL-33–dependent AD-like inflammation involving dendritic cell activation with a distinct type 2 immune response (Li et al., 2017Li C. Maillet I. Mackowiak C. Viala C. Di Padova F. Li M. et al.Experimental atopic dermatitis depends on IL-33R signaling via MyD88 in dendritic cells.Cell Death Dis. 2017; 8: e2735Crossref PubMed Scopus (41) Google Scholar). •IL-33–driven AD is independent of adaptive immunity.•Keratinocyte-derived IL-33 activates basophils, which induce ILC2s.•Basophil depletion in this context is of potential therapeutic interest. Imai et al., 2013Imai Y. Yasuda K. Sakaguchi Y. Haneda T. Mizutani H. Yoshimoto T. et al.Skin-specific expression of IL-33 activates group 2 innate lymphoid cells and elicits atopic dermatitis-like inflammation in mice.Proc Natl Acad Sci USA. 2013; 110: 13921-13926Crossref PubMed Scopus (323) Google Scholar established a transgenic mouse expressing IL-33 in keratinocytes driven by the keratin-14 promoter (IL33tg) that is characterized by epidermal hyperkeratosis as well as eosinophil and innate lymphoid cell type 2 (ILC2) infiltration. Now, the authors provide new insights into the pathophysiology of AD-like inflammation using their model (Imai et al., 2013Imai Y. Yasuda K. Sakaguchi Y. Haneda T. Mizutani H. Yoshimoto T. et al.Skin-specific expression of IL-33 activates group 2 innate lymphoid cells and elicits atopic dermatitis-like inflammation in mice.Proc Natl Acad Sci USA. 2013; 110: 13921-13926Crossref PubMed Scopus (323) Google Scholar) and ask how ILC2s and basophils contribute to the IL-33–induced AD-like inflammation (Imai et al., 2019Imai Y. Yasuda K. Nagai M. Kusakabe M. Kubo M. Nakanishi K. et al.IL-33–induced atopic dermatitis–like inflammation in mice is mediated by group 2 innate lymphoid cells in concert with basophils.J Invest Dermatol. 2019; 139: 2185-2194Abstract Full Text Full Text PDF PubMed Scopus (46) Google Scholar). Skin inflammation developed in B cell– and T cell–deficient Rag2KO IL33tg mice suggests that adaptive immune cells are dispensable. In contrast, the depletion of ILC2s accomplished via bone marrow transplantation from IL33tg to ILC2-lacking, RORα-deficient mice suppressed the development of AD-like inflammation. The authors then explored the role of the basophils in IL33tg skin inflammation. Specific depletion of basophils with the anti-FcεRIα antibody MAR1 (Sokol et al., 2008Sokol C.L. Barton G.M. Farr A.G. Medzhitov R. A mechanism for the initiation of allergen-induced T helper type 2 responses.Nat Immunol. 2008; 9: 310-318Crossref PubMed Scopus (760) Google Scholar), or conditional diphtheria toxin–induced basophil depletion using Bas-TRECK mice (Sawaguchi et al., 2012Sawaguchi M. Tanaka S. Nakatani Y. Harada Y. Mukai K. Matsunaga Y. et al.Role of mast cells and basophils in IgE responses and in allergic airway hyperresponsiveness.J Immunol. 2012; 188: 1809-1818Crossref PubMed Scopus (133) Google Scholar) crossed with the IL33tg mice, reduced AD-like inflammation. These results provide strong support for a critical role of basophils in this model, consistent with a previous report (Nakashima et al., 2018Nakashima C. Otsuka A. Kabashima K. Recent advancement in the mechanism of basophil activation.J Dermatol Sci. 2018; 91: 3-8Abstract Full Text Full Text PDF PubMed Scopus (25) Google Scholar). Moreover, the authors demonstrated that depletion of basophils in IL33tg skin reduces the accumulation of ILC2s and ILC2-derived cytokines and chemokines, including IL-5, IL-13, and CCL5. Therefore, the data suggest that keratinocyte-driven, IL-33–mediated AD-like inflammation may be initially and solely dependent on an innate immune response mediated by ILC2s acting in concert with basophils (Figure 1). The study is of interest because it shows that continuous expression of IL-33 in keratinocytes is sufficient to cause AD-like inflammation in mice, and that this occurrence is largely independent of adaptive immune cells and is mediated by basophils and ILC2s. ILC2s have emerged as important participants in early allergic responses in skin that pave the way for T helper type 2 cell responses. However, the observation that basophils are required for the ILC2 differentiation is novel and thus may open new therapeutic considerations. There are limitations of this model, because the mechanisms explored involve IL-33 production that is restricted to keratinocytes. AD in patients clearly depends on other inflammatory factors and cell types. In addition, RORα-dependent ILC2 depletion may affect cytokine production from group 3 innate lymphoid cells and T helper type 17 cells (Lo et al., 2016Lo B.C. Gold M.J. Hughes M.R. Antignano F. Valdez Y. Zaph C. et al.The orphan nuclear receptor ROR alpha and group 3 innate lymphoid cells drive fibrosis in a mouse model of Crohn's disease.Sci Immunol. 2016; 1: eaaf8864Crossref Scopus (54) Google Scholar). The roles of basophils and ILC2s should be investigated additionally in other experimental models of AD and in patients. IL-33–Induced Atopic Dermatitis–Like Inflammation in Mice Is Mediated by Group 2 Innate Lymphoid Cells in Concert with BasophilsJournal of Investigative DermatologyVol. 139Issue 10PreviewIL-33 is a proinflammatory cytokine that plays a pivotal role in allergic disorders. In a transgenic mouse expressing IL-33 driven by a keratin-14 promoter (IL33tg), atopic dermatitis (AD)-like inflammation develops spontaneously with the activation of group 2 innate lymphoid cells (ILC2s). However, it remains unknown how effector cells, such as T helper type 2 cells, ILC2s, and basophils, contribute to the inflammatory process induced by IL-33. To address the question, we examined the phenotype of IL33tg mice lacking each of these cells. Full-Text PDF Open Archive